May 2026
The global biosimilar monoclonal antibody market size is projected to hit around USD 124.43 billion by 2035 from USD 16.01 billion in 2025 with a CAGR of 22.76%.
July 2025
The global antibody therapy market size reached USD 313.47 billion in 2024 and is predicted to surpass around USD 973.60 billion by 2034, with a solid CAGR of 12%.
June 2026
The global immunology biosimilars market size was estimated at USD 11.23 billion in 2025 and is expected to hit around USD 56.39 billion by 2035, growing at a CAGR of 17.51%.
June 2026
The global psoriasis biosimilars market size is evaluated at USD 10.46 billion in 2025 and is projected to attain around USD 29.78 billion by 2035, with a CAGR of 11.03%.
May 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 241.03 billion in 2025, with a CAGR of 11.26%.
May 2026
The global antibody drug conjugates market size is projected to hit around USD 34.80 billion by 2035 from USD 12.69 billion in 2025 with a soild CAGR of 10.61%.
April 2026
The global cancer monoclonal antibodies market size reached USD 125.10 billion in 2025 and is predicted to hit around USD 658.07 billion by 2035, with a solid CAGR of 18.06%.
March 2026
The antibody production market size was estimated at USD 28.04 billion in 2025 and it is expected to surpass USD 93.76 billion by 2035 with a CAGR of 12.83%.
March 2026
The global biosimilars market size is exhibited at USD 40.36 billion in 2025 and is projected to hit around USD 191.29 billion by 2035, growing at a solid CAGR of 16.84%.
March 2026
The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 610.41 billion in 2025, with a CAGR of 14.80%.
March 2026
The global veterinary monoclonal antibodies market size is estimated to hit around USD 5.62 billion by 2035 increasing from USD 1.74 billion in 2025, with a CAGR of 12.44%.
February 2026
The global antibody purification service market size was evaluated at USD 3.01 billion in 2025 and is predicted to hit around USD 7.74 billion by 2035, growing at a CAGR of 9.90%.
January 2026
The global bispecific antibody therapeutics contract manufacturing market size was evaluated at USD 9.82 billion in 2025 and is predicted to hit around USD 218.92 billion by 2035, growing at a CAGR of 36.4%.
January 2026
The global next-generation bispecific antibody market size was evaluated at USD 9.53 billion in 2025 and is predicted to hit around USD 52.08 billion by 2035, growing at a CAGR of 18.51%.
January 2026
The global monoclonal antibodies market size is evaluated at USD 286.32 billion in 2025 and is projected to hit around USD 880.01 billion by 2035, with a CAGR of 11.88%.
January 2026
The global antibody discovery market size was estimated at USD 9.06 billion in 2025 and is projected to hit around USD 22.28 billion by 2035 with a CAGR of 9.42%.
August 2025
The global antibody ELISA kits for tropical infectious disease market size was valued at USD 2.39 billion in 2024 and is expected to hit around USD 4.41 billion by 2034, growing at a CAGR of 6.32%.
August 2025
The global anti-thyroid peroxidase antibody test kit market size was valued at USD 150.07 million in 2024 and is expected to hit around USD 341.19 million by 2034, growing at a CAGR of 8.56%.
July 2025
The global custom antibody market size was calculated at USD 192.80 million in 2024 and is expected to attain around USD 481.76 million by 2034 with a CAGR of 9.59%.
May 2025
The global neutralizing antibody market size is estimated to hit around USD 534.39 billion by 2034 increasing from USD 232.04 billion in 2024, with a CAGR of 8.70%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com